PET-CT–Based Auto-Contouring in Non–Small-Cell Lung Cancer Correlates With Pathology and Reduces Interobserver Variability in the Delineation of the Primary Tumor and Involved Nodal Volumes-Reference-Cited by-同舟云学术

PET-CT–Based Auto-Contouring in Non–Small-Cell Lung Cancer Correlates With Pathology and Reduces Interobserver Variability in the Delineation of the Primary Tumor and Involved Nodal Volumes

Published:2007-07 Issue:3 Volume:68 Page:771-778
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

van Baardwijk Angela,Bosmans Geert,Boersma Liesbeth,Buijsen Jeroen,Wanders Stofferinus,Hochstenbag Monique,van Suylen Robert-Jan,Dekker André,Dehing-Oberije Cary,Houben Ruud,Bentzen Søren M.,van Kroonenburgh Marinus,Lambin Philippe,De Ruysscher Dirk

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Oncology,Radiation

Reference48 articles.

1. Is there a standard strategy in the management of locally advanced non-small cell lung cancer?;Novello;Lung Cancer,2001

2. Final results of phase III trial in regionally advanced unresectable non-small cell lung cancer: Radiation Therapy Oncology Group, Eastern Cooperative Oncology Group, and Southwest Oncology Group;Sause;Chest,2000

3. Failure-specific prognostic factors after continuous hyperfractionated accelerated radiotherapy (CHART) or conventional radiotherapy in locally advanced non-small-cell lung cancer: A competing risks analysis;Ataman;Br J Cancer,2001

4. A randomized phase I/II trial of hyperfractionated radiation therapy with total doses of 60.0 Gy to 79.2 Gy: possible survival benefit with greater than or equal to 69.6 Gy in favorable patients with Radiation Therapy Oncology Group stage III non-small-cell lung carcinoma: report of Radiation Therapy Oncology Group 83-11.

5. Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer;Furuse;J Clin Oncol,1999

Cited by 255 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of PET/CT in Lung Cancer Radiotherapy;Nuclear Medicine Seminars;2023-11-01

2. A deep learning approach for automatic tumor delineation in stereotactic radiotherapy for non-small cell lung cancer using diagnostic PET-CT and planning CT;Frontiers in Oncology;2023-08-04

3. Interobserver Variability Prediction of Primary Gross Tumor in a Patient with Non-Small Cell Lung Cancer;Cancers;2022-11-29

4. Clinical validation of deep learning algorithms for radiotherapy targeting of non-small-cell lung cancer: an observational study;The Lancet Digital Health;2022-09

5. A pilot study investigating the role of ¹⁸ F‐FDG‐PET in the early identification of chemoradiotherapy response in anal cancer;Journal of Medical Radiation Sciences;2022-07-30